PCSK9 Inhibitor Treatment for Patients With SPG5
Clinical trial NCT04101643 · UNKNOWN
Trial details
- NCT number
- NCT04101643
- Sponsor
- First Affiliated Hospital of Fujian Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-29
- Primary completion
- 2023-01-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.